Jun 11, 2020
Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19
Jun 03, 2020
Distributed Bio Partners With Mediar Therapeutics, Inc.
May 08, 2020
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance
Apr 20, 2020
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001
Mar 17, 2020
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program
Jan 20, 2020
Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody
Dec 09, 2019
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody
Apr 18, 2019
TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease and Progressive Supranuclear Palsy
Mar 25, 2019
GigaGen Publishes Study in Peer-Reviewed Journal mAbs, Validating Feasibility and Benefit of Rapid Parallel Immunization Protocols for Discovery of Novel Monoclonal Antibodies
Mar 05, 2019
Global Biotech Market Primed for Growth With Renewed Research and Development Efforts
Feb 20, 2019
GigaGen Publishes Study Demonstrating Optimal Method for Selecting OX40 Therapeutic Candidates from Antibody Repertoires
Feb 06, 2019
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2018: Focus on Monoclonal Antibodies, Murine mAb, Chimeric mAb, Humanized mAb & Human aAb
Mar 28, 2018
Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement
Feb 21, 2018
Global Monoclonal Antibodies Market Hit $100 Billion in 2017: Report
Feb 05, 2018
Natively Paired Antibodies Are Better: Study by GigaGen in Collaboration with Global Biopharmaceutical Company Describes Novel Approach to Identifying Antibodies with High Therapeutic Potential
Sep 19, 2017
ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease
Sep 08, 2017
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2017